SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The topline surged 94.73% to Rs. 1997.47 millions for the September 2022 quarter as against Rs. 1025.74 millions during the corresponding quarter last year.Net Profit for the quarter ended September 2022 zoomed to 101.89% from Rs. 90.63 millions to Rs. 182.97  millions.Operating profit for the quarter ended September 2022 rose to 372.63 millions as compared to 219.85 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1997.47 1025.74 94.73 3840.13 2312.31 66.07 6765.66 5548.72 21.93
Other Income 39.82 8.99 342.94 66.89 17.03 292.78 104.63 76.71 36.40
PBIDT 372.63 219.85 69.49 654.22 474.61 37.84 1645.47 1191.77 38.07
Interest 45.21 16.59 172.51 84.51 31.97 164.34 90.90 47.90 89.77
PBDT 327.42 203.26 61.08 569.71 442.64 28.71 1554.57 1143.87 35.90
Depreciation 81.84 81.67 0.21 171.26 146.89 16.59 344.16 257.15 33.84
PBT 245.58 121.59 101.97 398.45 295.75 34.73 1210.41 886.72 36.50
TAX 62.61 30.96 102.23 101.58 75.38 34.76 312.23 239.79 30.21
Deferred Tax 46.35 3.56 1201.97 75.46 4.52 1569.47 26.10 -6.12 -526.47
PAT 182.97 90.63 101.89 296.87 220.37 34.71 898.18 646.93 38.84
Equity 196.05 195.89 0.08 196.05 195.89 0.08 195.98 195.88 0.05
PBIDTM(%) 18.66 21.43 -12.96 17.04 20.53 -17.00 24.32 21.48 13.23

Astec Lifesciences Share Price

726.50 -22.90 (-3.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×